"Dr. Valerie Callender is an internationally recognized Board Certified Dermatologist and who is known for her sensitive and cutting-edge approach to management of hair loss in women, the treatment of pigmented disorders and is also a prolific contributor to the dermatology literature. She has co-edited a textbook on Treatment for Skin of Color and has written 18 textbook chapters and more than 45 peer-reviewed articles for academic journals. Dr. Callender is a frequently invited speaker to national and international meetings, where she has made more than 160 presentations, including presentations in Australia, Brazil, Canada, the Czech Republic, Germany, India, Portugal, South Africa, United Kingdom, and many others. Dr."

During the past decade, Callender Center for Clinical Research conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Callender Center for Clinical Research" #1 sponsor was "Callender Center for Clinical Research" with 3 trials, followed by "Kythera Biopharmaceuticals" with 2 trials sponsored, "Actavis Inc." with 1 trials sponsored, "Allergan" with 1 trials sponsored and "Galderma R&D" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Callender Center for Clinical Research" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator and "Society Hill Dermatology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Callender Center for Clinical Research" are "Acne" (1 trials), "Acne Vulgaris" (1 trials), "Alopecia" (1 trials), "Atopic Dermatitis" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Callender Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Callender Center for Clinical Research" are "Drug" (9 trials), "Device" (4 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Vehicle cream" (2 trials), "ATX-101" (1 trials), "Benzoyl peroxide gel" (1 trials) and "Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Callender Center for Clinical Research" are 11 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Callender Center for Clinical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Callender Center for Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Callender Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".